Dissertation > Excellent graduate degree dissertation topics show
Clinical Characteristics and Prognostic Analyze of Acutemyeloid Leukemia Cases with MLL Gene Rearrangement
Author: JiGuo
Tutor: SunAiNing
School: Suzhou University
Course: Hematology
Keywords: MLL gene rearrangement acute myeloid leukemia chemotherapy allo-hematopoietic stem cell transplantion
CLC: R733.71
Type: Master's thesis
Year: 2013
Downloads: 20
Quote: 0
Read: Download Dissertation
Abstract
|
Objective:To investigate the clinical characteristics and prognosis of acute myoloid leukimia cases with MLL gene rearrangement.Methods:51de novo MLL gene rearrangement AML (non M3) cases hospitalized during2006-2009were compared with51cases without MLL gene rearrangement (the control group) admitted in the same period, all of which were diagnosed in accordance with MICM criteria. Before induction chemotherapy, pretreatment was used to decrease the quantity of WBC when the count was higher than50×109/L. The induction regimen included triple therapy which consisted of homoharringtonine、standard-dose cytarabine and daunorubicin(HAD regimen) or mitoxantrone(HAM regimen) and double therapy which consisted of daunorubicin or mitoxantrone/idarubicin with standard-dose cytarabine. The patients who achived complete remission received allo-HSCT when they had the indication for transplantation and were successful in HLA matching. The rest received1~4cycles of mitoxantrone or daunorubicin/idarubicin with ieter-dose cytarabine (1.0~2.0g/m2·q12h·3d) for the purpose of consolidation chemotherapy. The refractory or relapsed patients were treated with CAG(G-CSF、aclacinomycin and cytarabine) or FLAG(fludarabine、cytarabine and G-CSF)regimen. The clinical features、cytomorphology、immunophenotype、cytogenetics、early death、complete remission rate、recurrence rate、overall survival and response to allo-HSCT of AML patients with MLL gene rearrangement were investigated and compared with the control group at the same time.Results:1. Compared with the control group, the WBC coun、LDH levels、 percentage of peripheral blood blast cells in patients with MLL gene rearrangement increased notably (P<0.05); otherwise, the percentage of M4/M5in these patient was much higher according to FAB classification (P<0.05). 2. The expression of monocytic antigens such as CD14、CD64、CD15、CD11b in patients with MLL gene rearrangement were much higer than the control group (P <0.05).3.(1) The total CR rate of AML patients with MLL gene rearrangement was51.0%. Among the patients who achieved CR in this group,10cases received allo-HSCT and11cases relapsed in half a year, with the recurrence rate of42.3%. Meanwhile, the total CR rate of the control group was72.5%. Among which19cases received allo-HSCT and8cases relapsed in half a year, with the recurrence rate of21.6%. It can be seen that the AML patients with MLL gene rearrangement gained lower CR rate and were easier to relapse compared with the control group (P<0.05).(2) Among the patients with MLL gene rearrangement,14cases survived(6cases after HSCT,8cases after chemotherapy) and37cases died at the end of the follow-up, resulting in32.3%of OS rate. By contrast,29cases survived(14cases after HSCT,15cases after chemotherapy) and22cases died in the control group, resulting in62.5%of OS rate. Therefore, the OS of AML patients with MLL gene rearrangement was lower than that in the control group obviously(P<0.05).(3) Among the patients with MLL gene rearrangement, the cases who received allo-HSCT acquired3-year OS of60.0%vs26.7%in cases with simple chemotherapy, resulting in a higher OS obviously(P<0.05).Conclusions:The AML with MLL gene rearrangement is highly correlated with M4/M5, the patients of which show poor response to chemotherapy, high recurrence rate and poor prognosis. Hematopoietic stem cell transplantation may be a reasonable treatment principle to improve these patients’survival situation.
|
Related Dissertations
- Study of Sepia Ink-Astragalus Preparation for Relieving Damage Caused by Chemotherapy,R285.5
- Yu Ren- Cun Academic Thought and clinical experience in the clinical observation of combination chemotherapy in advanced gastric cancer with Yiqihuoxuejiedu side,R249
- Inhibition of Conventional Chemotherapy Combined with Metronomic Chemotherapy on Breast Cancer Xenografts in Nude Mice,R737.9
- Comparative Analysis on CTF and CEF Regimens as Postoperative Adjuvant Chemotherapy in the Treatment of Phase Ⅱ Breast Cancer,R737.9
- Effects on Telomere Length of Epithelial Ovarian Cancer by Chemotherapy,R737.31
- Recurrent Ovarian Cancer Surgery Again with Surial Analysis of Relevant Factors,R737.31
- Clinical Observation of Pemetrexed for Treating Advanced Non-small Cell Lung Cancer,R734.2
- The Experimental Study of Antiangiogenic and Induction of Apoptosis by Maximum Tolerated Dose Combined with Low-dose Cyclophosphamide in Breast Cancer,R737.9
- Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
- The Shrink Pattern of Breast Cancer After Neoadjuvant Chemotherapy and the Correlation with Partial Clinic Pathological Factors: Preliminary Results of a Plot Study,R737.9
- The Relationship between CEF/TE Neo-adjuvant Chemotherapy, MAPK/PI3K Signal Pathway and Ki-67 in Breast Cancer,R737.9
- The Protective Effects of Glucagon-like Peptide -2 on Intestinal Barrier Function of Doxorubicin Chemotherapy in Rats,R730.5
- Effect of the Function of MRP1 on Human Lung Adenocarcinoma Chemotherapy Resistance,R734.2
- The Effect and Significance of Combination Chemotherapy in the Expression of CD90 and CD44 in Human Hepatoma Cell Line HepG2,R735.7
- The Expression and Clinical Significance of Ercc1 in Human Gastric Cancer,R735.2
- Clinical Characteristics and Prognosis Analysis of Advanced Cholan Giocarcinoma,R735.8
- Expression and Prognostic Significance of TS and BRCAl mRNA in Non-small Cell Lung Cancer,R734.2
- Clinical Study on Effect of Xie Shi Lung Cancer NO.2 in Malignant Pleural Effusion of Lung Cancer,R734.2
- Glioma resistance related gene expression and its clinical significance,R739.4
- Low- dose cisplatin liver cancer stem cells enriched experimental study,R735.7
- Cancer patients before and after chemotherapy changes in blood glucose and glycosylated hemoglobin,R587.1
CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Leukemia > Acute leukemia
© 2012 www.DissertationTopic.Net Mobile
|